Literature DB >> 9370399

Dynamic cardiomyoplasty: clinical follow-up at 12 years.

J C Chachques1, J P Marino, P Lajos, R Zegdi, N D'Attellis, P Fornes, J N Fabiani, A Carpentier.   

Abstract

OBJECTIVE: The purpose of this study is to evaluate the long-term outcome of dynamic cardiomyoplasty. This surgical technique was conceived to assist the failing heart. The many proposed mechanisms of action of cardiomyoplasty are: (1) systolic assist; (2) limitation of ventricular dilation; (3) reduction of ventricular wall stress (sparing effect); (4) ventricular remodeling with an active girdling effect; (5) angiogenesis; and (6) a neurohumoral effect.
METHODS: We investigated 95 patients in our hospital undergoing this procedure due to severe chronic heart failure, refractory to optimal medical treatment. Patients had a mean age of 51 +/- 12 years. The etiology of heart failure was ischemic 55%, idiopathic 34%, ventricular tumor 6%, and other 5%. The mean follow-up was 44 months.
RESULTS: The mean New York Heart Association (NYHA) functional class improved postoperatively from 3.2 to 1.8. Average radioisotopic left ventricular (LV) ejection fraction increased from 17 +/- 5 to 27 +/- 4% (P < 0.05). Stroke volume index increased from 32 +/- 7 to 43 +/- 8 ml/beat per m2 (P < 0.05). The heart size remained stable over the long term. Following cardiomyoplasty, the number of hospitalizations due to congestive heart failure was reduced to 0.4 hospitalizations/patient per year (preoperative: 2.5, P < 0.05). Computed tomography scans showed at long term a preserved latissimus dorsi muscle structure in 84% of patients. Survival probability at 7 years is 54%. Six patients underwent heart transplant after cardiomyoplasty (mean delay: 25 months), due to the natural evolution of their underlying heart disease. There were no specific technical difficulties.
CONCLUSIONS: Clinically, this procedure reverses heart failure, improves functional class and ameliorates quality of life. The latissimus dorsi muscle histological structure is maintained at long-term, when postoperative electrostimulation is performed, avoiding excessive stimulation. Cardiomyoplasty may delay or prevent the progression of heart failure and the indication of cardiac transplantation.

Entities:  

Mesh:

Year:  1997        PMID: 9370399     DOI: 10.1016/s1010-7940(97)00214-5

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

Review 1.  Dynamic cardiomyoplasty as a therapeutic alternative: current status.

Authors:  L F Moreira; N A Stolf
Journal:  Heart Fail Rev       Date:  2001-09       Impact factor: 4.214

2.  Girdling effect of adynamic cardiomyoplasty in a model of dilated cardiomyopathy.

Authors:  Yoshio Ootaki; Takuro Tsukube; Yutaka Okita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-03

3.  First Turkish experience with the MicroMed DeBakey VAD.

Authors:  Deniz Suha Kucukaksu; Erol Sener; Akif Undar; George P Noon; Oguz Tasdemir
Journal:  Tex Heart Inst J       Date:  2003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.